Kathleen Tregoning
Director/Board Member bei SPERO THERAPEUTICS, INC.
Vermögen: 450 852 $ am 31.03.2024
Profil
Kathleen Tregoning is currently an Independent Director at Spero Therapeutics, Inc. since 2021 and the Chief Corporate Affairs Officer at Cerevel Therapeutics Holdings, Inc. since 2020.
Previously, she served as the Executive Vice President-External Affairs at Sanofi from 2017 to 2020.
She also held the position of Senior Vice President-Corporate Affairs at Biogen France SAS.
Ms. Tregoning completed her undergraduate degree at Stanford University and her graduate degree at Harvard Kennedy School of Government.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.01.2024 | 10 666 ( 0,01% ) | 450 852 $ | 31.03.2024 | |
SPERO THERAPEUTICS, INC.
-.--% | 08.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Kathleen Tregoning
| Unternehmen | Position | Beginn |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Public Communications Contact | 01.07.2020 |
| SPERO THERAPEUTICS, INC. | Director/Board Member | 11.10.2021 |
Ehemalige bekannte Positionen von Kathleen Tregoning
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Public Communications Contact | 01.03.2020 |
Biogen France SAS
 Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Ausbildung von Kathleen Tregoning
| Stanford University | Undergraduate Degree |
| Harvard Kennedy School of Government | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SANOFI | Health Technology |
| SPERO THERAPEUTICS, INC. | Health Technology |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Biogen France SAS
Biogen France SAS BiotechnologyHealth Technology Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France. | Health Technology |
